End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas

• Published in: Blood Vol. 138; no. Supplement 1; p. 3506
• Main Authors: Mehta-Shah, Neha, Jacobsen, Eric D, Fehniger, Todd A., Kahl, Brad S., Bartlett, Nancy L., Cashen, Amanda F., Ghobadi, Armin, Reagan, Beth, Fischer, Anne, Moskowitz, Alison J., Wan, Fei, Jacobsen, Austin, Olson, Meredith, Vigil, Edgar, Hill, Natalie, Elias, Karina, Huang, Ying, Horwitz, Steven M.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 23.11.2021

Introduction: Peripheral T-cell lymphomas (PTCL) are a rare subset of non-Hodgkin lymphomas in which approximately 80% patients will have an overall response to CHOP based therapy but 5-year survival ranges between 20-40%. (Ellin et al Blood 2014) While response by PET/CTs have been helpful in risk...